Medical Research Council - London Institute of Medical Sciences

Now in our 11th year of bringing you beautiful imagery from biomedical science every day

Editing Better Muscles

Maximising gene editing to repair the mutated dystrophin gene responsible for Duchenne muscular dystrophy

03 April 2019

Editing Better Muscles

Duchenne muscular dystrophy (DMD) is a severe muscle wasting disease caused by mutations to dystrophin – a protein inside muscle cells that provides essential mechanical stability. Without functional dystrophin, DMD sufferers gradually lose muscle strength, become increasingly frail, have trouble breathing and generally don't live past their 30s. The nature of the dystrophin mutations is such that gene-editing technology has been posited as a potential treatment. Indeed, engineered mice and dogs carrying DMD mutations have had functional dystrophin partly restored as a result of gene editing. Scientists are now optimising the technique to maximise its efficiency in human cells. The image shows heart cells derived from reprogrammed DMD patient cells before (left) and after (right) gene editing to restore dystrophin (red). These technical successes in mammalian models and patient cells brings the promise of a gene-editing treatment for DMD one step closer to reality.

Written by Ruth Williams

Search The Archive

Submit An Image

What is BPoD?

BPoD stands for Biomedical Picture of the Day. Managed by the MRC London Institute of Medical Sciences the website aims to engage everyone, young and old, in the wonders of biomedicine. Images are kindly provided for inclusion on this website through the generosity of scientists across the globe.

Read More

BPoD is also available in Catalan at www.bpod.cat with translations by the University of Valencia.